Pharma's Almanac TV
PA TV
Your Name
Your Email
Manage Account
Sign Out
Sign In
Register
Follow the Journey
Companies On The Road
Arcadis DPS Group
C2 Pharma
CAI
EcoLab
Environmental Systems Corporation
Federal Equipment Company
Globyz Biopharma Services
Grifols
Integrity
Nu-Tek BioSciences
PHARMALEX
Waters Corporation
Follow the Completed Journey
Companies On The Road
Follow The Artist
ABS
aCGT Vector
Alconox Inc.
Andelyn Biosciences
Arranta Bio
Avid Bioservices
BDD
BIOVECTRA
DPS Group
Dynamk Capital
Environmental Systems Corporation
Federal Equipment Company
Genesis AEC
Globyz Biopharma Services
Grifols Partnership
IDT Biologika
Inceptor Bio
IPS-Integrated Project Services
Kineticos Life Sciences
MilliporeSigma
Montana BioScience Alliance
Olon
Rentschler Biopharma
SanaClis
Scorpion Biological Services
Secant Group
Tapemark
VITRONIC
Follow the Completed Journey
Companies We've Met
AES Clean Technology
Altis Biosystems
Arranta Bio
Avara Pharmaceutical Services
Avid Bioservices
BioVectra
Centaur BPS
Dynamk Capital
ECRI
Evolve Biologics
Federal Equipment Company
Globyz
Inceptor Bio
IPS-Integrated Project Services
Olon
Pii
Polpharma Biologics
PPD
RoosterBio
SanaClis
Sanofi AIS
SGD Pharma
SPI Pharma
TriRx Pharmaceutical Services
Yourway
Dashboard
Topics
Products
ADC
API - Small Molecule
Biologics
Biopharmaceuticals
Biosimilars
Cell and Gene Therapy
DNA
Drug Product
Drug Substance
Equipment
Generics
Immunotherapy
Injectables
Monoclonal Antibody
Novel Therapeutics
Oral Solid Dosage
Orphan Drugs
Parenterals
Stem Cells
Vaccine
Services
Big Data
Bioprocessing
Clinical Trials
Continuous Manufacturing
Diagnostics
Drug Delivery
Drug Development
Drug Discovery
Facility
Formulation
Innovation
Oncology
Patient Adherence
Patient Centric
Preclinical
Process Development
Quality
Regulatory
Research
Serialization
Segment
Biomanufacturing
Biotechnology
CDMO
Consulting
CRO
Engineering
Equipment
Excipients
Healthcare
Intermediates
Logistics
Manufacturing
Packaging
Supply Chain
Business
Agreement
Appointment
Business
Capacity Expansion
Collaboration
Growth
Investment
Licensing
M&A
Market Expansion
Market Intelligence
Market Prediction
New Facility
Strategic Partnership
Magazine
Archive
Reports
2023 Nice Insight Reports
Cell & Gene Therapy: 2023 Market Analysis, CDMO Pricing and Benchmarking
Monoclonal Antibody & Recombinant Protein: 2023 Market Analysis, CDMO Pricing and Benchmarking
mRNA Vaccines & Therapeutics: 2023 Market Analysis, CDMO Pricing and Benchmarking
Sterile Drug Product: 2023 Market Analysis, CDMO Pricing and Benchmarking
Active Pharmaceutical Ingredients: 2023 Market Analysis, CDMO Pricing and Benchmarking
Antibody Drug Conjugates: 2023 Market Analysis, CDMO Pricing and Benchmarking
Contract Research Organizations: 2023 Market Analysis, Pricing and Benchmarking
Oral Solid Dosage: 2023 Market Analysis, CDMO Pricing and Benchmarking
Community
Company A to Z
Follow the Journey
Companies On The Road
Follow The Artist
Follow the Journey
Companies On The Road
More+
Staffing
Media Kit
Oral Solid Dosage
26 Articles Available
1
2
Can't find what you're looking for? Try our
advanced search
.
Advanced Excipients
How the Developability Classification System and Advanced Excipients Enable the Formulation of Poorly Soluble APIs
PAO-04-022-CL-07
Specialized OSD Services
Avara Pharmaceutical Services: Specialization with a Client-Centric Approach
PAP-Q4-20-CL-003
The Future of Healthcare
How Does Avara Pharmaceutical Services Envision the Future of the Pharma/Biopharma Industry?
PAP-Q4-20-RT2-011
The Future of Healthcare
How Is Avara Pharmaceutical Services Evolving its Business Model to Meet the Future of Healthcare?
PAP-Q3-20-RT2-003
Over-the-Counter Conversions
Avara Pharmaceutical Services: Achieving Successful OSD Rx-to-OTC Conversions
PAP-Q3-20-CL-007
The Future of Healthcare
How is Avara Innovating through the Pandemic and Beyond to Define the Future of Healthcare?
PAP-Q2-20-RT2-010
The Future of Healthcare
How is Avara Preparing to Face the Future of Healthcare?
PAP-Q1-20-R2-006
Core Capabilities
Concentrating on Core OSD & Sterile Capabilities for Assured Client Success
PAP-Q1-20-CL-034
OSD
Oral Solid Dose Manufacturing for Customers Now and into the Future
PAP-Q2-2019-CL-010
Diabetes
Novo Nordisk to Use Priority Voucher for Diabetes Drug
PAO-M02-19-NI-004
Probiotics
Hard-Shell Capsule Solutions for Sensitive Compounds: A Focus on Probiotics
PAO-M12-18-CL-002
Capsule
How to Tell If You’re Using a Quality Hard Capsule
PAO-M11-18-CL-001
Oral Solid Dose
HPAPIs and Two-Piece Liquid-Fill Capsules: The Perfect Match
PAO-06-18-CL-001
OSD Facility Design
Modern OSD Facility Design Considerations for Operational Efficiency and Regulatory Compliance
PAP-Q2-18-CL-012
Equipment
Successful Solid Dose Equipment Training
PA0-M04-18-CL-004
Bioequivalence Study
Biohaven Announces Positive Results From Bioequivalence Study With Sublingual BHV-0223 Zydis® Orally Dissolving Tablet
PR-M01-18-NI-034
Solid Dose
O'Hara Technologies Inc., Evonik, Colorcon® and Techceuticals LLC to Provide Solid Dose Pharmaceuticals Technologies Training at Federal Equipment Company
PR-M09-17-NI-007
Facility
Oral Solid Dose Manufacturing Efficiency is Driving New Attention to Plant Design
PAP-Q3-17-CL-002
Oral Solid Dosage
Nice Symposium Oral Solid Dose 2017: Bringing the Supply Chain Together to Tackle Development Challenges
PAP-Q2-17-NS-001
Batch to Continuous: Changing Customer Mindset
PTV-M03-17-IN-002
The Introduction of Robotics: Creating a Truly Sterile Environment
PTV-M03-17-IN-001
Meeting Customer Needs
PTV-M01-17-NS-014
Oral Solid Dose Train-the-Trainer for Production Personnel
PTV-M01-17-NS-007
An OEE Approach To Solid Dose Equipment Purchasing and Implementation
PAP-Q1-17-CL-005
1
2
»
